Frontiers | Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type
How do I distinguish cholangiocarcinoma from metastatic carcinoma and why does it matter? - ScienceDirect
Frontiers | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
Biliary Tract Cancers | NEJM
Cholangiocarcinoma - YouTube
Significance of serum and bile tumor markers in the diagnostic approach of patients with malignant pancreatobiliary disease. | Semantic Scholar
Bile Duct Cancer (Cholangiocarcinoma) | Johns Hopkins Medicine
Pathology of Cholangiocarcinoma and Combined Hepatocellular‐ Cholangiocarcinoma - Krishna - 2021 - Clinical Liver Disease - Wiley Online Library
Surgical management of cholangiocarcinoma
Cholangiocarcinoma
Cholangiocarcinoma
March 2012 Residency Program Case of the Month | Department of Pathology UC Davis Health System
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update | Gut
Establishment and Characterization of a Cholangiocarcinoma Cell Line from a Thai Patient with Intrahepatic Bile Duct Cancer
![PDF] Serum Markers of Intrahepatic Cholangiocarcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1fc268883b0831b6fe2dfbf376ed5fd1d8aba128/6-Table1-1.png "PDF] Serum Markers of Intrahepatic Cholangiocarcinoma | Semantic Scholar")
PDF] Serum Markers of Intrahepatic Cholangiocarcinoma | Semantic Scholar
Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology & Hepatology
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma | Scientific Reports
Surface Markers of Cancer Stem Cells in Cholangiocarcinoma (CCA). | Download Scientific Diagram
Cancers | Free Full-Text | Prognostic and Predictive Molecular Markers in Cholangiocarcinoma | HTML
Cholangiocarcinoma - The Lancet
Tumor marker analysis in the cases with and without cholangiocarcinoma | Download Table
Phenotype markers of candidate cholangiocarcinoma cells of origin | Download Table
![PDF] Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/942919bec9429e21c4d8ed2b634a865a13da7cad/3-Table2-1.png "PDF] Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma | Semantic Scholar")
PDF] Anti-NY-ESO-1 autoantibody may be a tumor marker for intrahepatic cholangiocarcinoma | Semantic Scholar
Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009
